Arbutus Biopharma Corp (ABUS)
3.21
+0.14
(+4.56%)
USD |
NASDAQ |
May 21, 16:00
3.20
-0.01
(-0.31%)
After-Hours: 05:14
Arbutus Biopharma Accounts Receivable (Quarterly): 2.139M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.139M |
December 31, 2023 | 1.776M |
September 30, 2023 | 2.171M |
June 30, 2023 | 2.614M |
March 31, 2023 | 2.664M |
December 31, 2022 | 1.352M |
September 30, 2022 | 1.835M |
June 30, 2022 | 1.97M |
March 31, 2022 | 1.313M |
December 31, 2021 | 0.899M |
September 30, 2021 | 1.667M |
June 30, 2021 | 1.298M |
March 31, 2021 | 1.265M |
December 31, 2020 | 1.312M |
September 30, 2020 | 1.075M |
June 30, 2020 | 1.108M |
March 31, 2020 | 1.072M |
December 31, 2019 | 1.204M |
September 30, 2019 | 2.488M |
June 30, 2019 | 1.531M |
March 31, 2019 | 0.923M |
December 31, 2018 | 1.431M |
September 30, 2018 | 0.538M |
June 30, 2018 | 1.322M |
March 31, 2018 | 0.719M |
Date | Value |
---|---|
December 31, 2017 | 0.402M |
September 30, 2017 | 0.846M |
June 30, 2017 | 1.042M |
March 31, 2017 | 7.878M |
December 31, 2016 | 0.273M |
September 30, 2016 | 0.395M |
June 30, 2016 | 0.456M |
March 31, 2016 | 0.34M |
December 31, 2015 | 1.008M |
September 30, 2015 | 2.192M |
June 30, 2015 | 6.332M |
March 31, 2015 | 4.564M |
December 31, 2014 | 1.903M |
September 30, 2014 | 2.094M |
June 30, 2014 | 0.299M |
March 31, 2014 | 1.521M |
December 31, 2013 | 0.117M |
September 30, 2013 | 3.981M |
June 30, 2013 | 1.646M |
March 31, 2013 | 1.468M |
December 31, 2012 | 1.075M |
September 30, 2012 | 2.080M |
June 30, 2012 | 1.925M |
March 31, 2012 | 2.444M |
December 31, 2011 | 0.8626M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.899M
Minimum
Dec 2021
2.664M
Maximum
Mar 2023
1.638M
Average
1.442M
Median
Accounts Receivable (Quarterly) Benchmarks
Moderna Inc | 137.00M |
Pfizer Inc | 10.99B |
Regeneron Pharmaceuticals Inc | 5.222B |
Chimerix Inc | 0.001M |
Karyopharm Therapeutics Inc | 31.08M |